Armata Pharmaceuticals, Inc. — Director's Dealing 2021

Mar 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2021-03-25

Reporting Person: Varnum Brian (President and CDO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-25	Stock Option (Right to Buy)	$5.14	A	112000	Acquired	2031-03-25	Common Stock (112000)	Direct

Footnotes

F1: The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant.